Somatostatin receptor scintigraphy and somatostatin therapy in the evaluation and treatment of malignant thymoma

Ke Lin; Ba D. Nguyen; David S. Ettinger; Bennett B. Chin

doi:10.1097/00003072-199901000-00006

Somatostatin receptor scintigraphy and somatostatin therapy in the evaluation and treatment of malignant thymoma

Ke Lin, Ba D. Nguyen, David S. Ettinger, Bennett B. Chin

School of Medicine

Research output: Contribution to journal › Article › peer-review

35 Scopus citations

Abstract

Purpose: This report illustrates the potential diagnostic and therapeutic utility of somatostatin receptor scintigraphy and therapy with somatostatin. Methods: In-111 pentetreotide (In-11 octreotide), a somatostatin analog, was used to define the receptor status and the extent of disease in a case of malignant thymoma. Results: Subsequent treatment with nonradioactive somatostatin inhibited tumor growth. Conclusion: In-111 octreotide may be useful to define tumor receptor status and may provide prognostic information useful in determining subsequent therapy.

Original language	English (US)
Pages (from-to)	24-28
Number of pages	5
Journal	Clinical nuclear medicine
Volume	24
Issue number	1
DOIs	https://doi.org/10.1097/00003072-199901000-00006
State	Published - Jan 1999

Keywords

In-111-Octreotide Scintigraphy
Somatostatin Therapy
Thymoma

ASJC Scopus subject areas

Radiology Nuclear Medicine and imaging

Access to Document

10.1097/00003072-199901000-00006

Cite this

@article{4a18992117e745afbaa0b59c29edfda1,

title = "Somatostatin receptor scintigraphy and somatostatin therapy in the evaluation and treatment of malignant thymoma",

abstract = "Purpose: This report illustrates the potential diagnostic and therapeutic utility of somatostatin receptor scintigraphy and therapy with somatostatin. Methods: In-111 pentetreotide (In-11 octreotide), a somatostatin analog, was used to define the receptor status and the extent of disease in a case of malignant thymoma. Results: Subsequent treatment with nonradioactive somatostatin inhibited tumor growth. Conclusion: In-111 octreotide may be useful to define tumor receptor status and may provide prognostic information useful in determining subsequent therapy.",

keywords = "In-111-Octreotide Scintigraphy, Somatostatin Therapy, Thymoma",

author = "Ke Lin and Nguyen, {Ba D.} and Ettinger, {David S.} and Chin, {Bennett B.}",

year = "1999",

month = jan,

doi = "10.1097/00003072-199901000-00006",

language = "English (US)",

volume = "24",

pages = "24--28",

journal = "Clinical nuclear medicine",

issn = "0363-9762",

publisher = "Lippincott Williams and Wilkins",

number = "1",

}

TY - JOUR

T1 - Somatostatin receptor scintigraphy and somatostatin therapy in the evaluation and treatment of malignant thymoma

AU - Lin, Ke

AU - Nguyen, Ba D.

AU - Ettinger, David S.

AU - Chin, Bennett B.

PY - 1999/1

Y1 - 1999/1

N2 - Purpose: This report illustrates the potential diagnostic and therapeutic utility of somatostatin receptor scintigraphy and therapy with somatostatin. Methods: In-111 pentetreotide (In-11 octreotide), a somatostatin analog, was used to define the receptor status and the extent of disease in a case of malignant thymoma. Results: Subsequent treatment with nonradioactive somatostatin inhibited tumor growth. Conclusion: In-111 octreotide may be useful to define tumor receptor status and may provide prognostic information useful in determining subsequent therapy.

AB - Purpose: This report illustrates the potential diagnostic and therapeutic utility of somatostatin receptor scintigraphy and therapy with somatostatin. Methods: In-111 pentetreotide (In-11 octreotide), a somatostatin analog, was used to define the receptor status and the extent of disease in a case of malignant thymoma. Results: Subsequent treatment with nonradioactive somatostatin inhibited tumor growth. Conclusion: In-111 octreotide may be useful to define tumor receptor status and may provide prognostic information useful in determining subsequent therapy.

KW - In-111-Octreotide Scintigraphy

KW - Somatostatin Therapy

KW - Thymoma

UR - http://www.scopus.com/inward/record.url?scp=0032932392&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032932392&partnerID=8YFLogxK

U2 - 10.1097/00003072-199901000-00006

DO - 10.1097/00003072-199901000-00006

M3 - Article

C2 - 9890489

AN - SCOPUS:0032932392

SN - 0363-9762

VL - 24

SP - 24

EP - 28

JO - Clinical nuclear medicine

JF - Clinical nuclear medicine

IS - 1

ER -

Somatostatin receptor scintigraphy and somatostatin therapy in the evaluation and treatment of malignant thymoma

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this